Skip to main content

Biosimilars

Biosimilars
Biosimilars—Are We There Yet?
Read More
Biosimilars, Cardiometabolic Health, FDA Approvals
FDA OKs Rapid-Acting Insulin Biosimilar Product
Read More
Biosimilars
Oncologists’ Common Misconceptions About Biosimilars Revealed in a Recent Survey
Read More
Review Article, Biosimilars, Practice Management
Implementation Strategies of Biosimilars in Healthcare Systems: The Path Forward
Raymond K. Cross, MD, MS, Amy L. Stewart, MSN, RN, FNP-C, Colin C. Edgerton, MD, FACP, FACR, RhMSUS, Bhavesh Shah, RPh, BCOP, John A. Welz, MPH, Jonathan Kay, MD
Raymond K. Cross, MD, MS; Amy L. Stewart, MSN, RN, FNP-C; Colin C. Edgerton, MD, FACP, FACR, RhMSUS; Bhavesh Shah, RPh, BCOP; John A. Welz, MPH; Jonathan Kay, MD
Read More
FDA Approvals, Biosimilars, Dermatology
Tremfya (Guselkumab), a Novel One-Press Patient-Controlled Injection, Approved for Moderate-to-Severe Plaque Psoriasis
Loretta Fala
Loretta Fala
Read More
Biosimilars
Is a Biologic Produced 15 Years Ago a Biosimilar of Itself Today?
Stanton R. Mehr, Marj P. Zimmerman, BSPharm, MS
Read More

Results 1 - 6 of 6